Synthetic buffer composition for clinical use
First Claim
Patent Images
1. A method for treating acidosis in a patient, said method comprising administering to a patient in need thereof an effective amount of a buffering solution, said buffering solution comprised of:
- (a) water;
(b) at least one N-substituted aminosulfonic acid selected from the group consisting of BES, DIPSO, HEPES, MOPS, MOPSO, TAPSO and TES; and
(c) at least one sodium salt of an N-substituted aminosulfonic acid selected from the group consisting of NaBES, NaDIPSO, NaHEPES, NaMOPS, NaMOPSO, NaTAPSO and NaTES where the N-substituted aminosulfonic acid from which the sodium salt is formed is different than the N-substituted aminosulfonic acid selected in (b).
2 Assignments
0 Petitions
Accused Products
Abstract
Methods of administering aqueous synthetic buffer compositions of an N-substituted aminosulfonic acid and a sodium salt of a different substituted aminosulfonic acid suitable to treat oligemic, respiratory and metabolic acidosis are disclosed. Methods of administering aqueous synthetic buffer compositions of a different N-substituted aminosulfonic acid, a sodium salt of an N-substituted aminosulfonic acid and tris(hydroxymethyl)aminomethane which may be similarly employed are also disclosed.
13 Citations
32 Claims
-
1. A method for treating acidosis in a patient, said method comprising administering to a patient in need thereof an effective amount of a buffering solution, said buffering solution comprised of:
-
(a) water; (b) at least one N-substituted aminosulfonic acid selected from the group consisting of BES, DIPSO, HEPES, MOPS, MOPSO, TAPSO and TES; and (c) at least one sodium salt of an N-substituted aminosulfonic acid selected from the group consisting of NaBES, NaDIPSO, NaHEPES, NaMOPS, NaMOPSO, NaTAPSO and NaTES where the N-substituted aminosulfonic acid from which the sodium salt is formed is different than the N-substituted aminosulfonic acid selected in (b). - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10)
-
-
11. A method for treating general and myocardial acidosis of a patient subjected to trauma and/or hemorrhage, said method comprising administering to a patient in need thereof an effective amount of a buffering solution, said buffering solution comprised of:
-
(a) water; (b) at least one N-substituted aminosulfonic acid selected from the group consisting of BES, DIPSO, HEPES, MOPS, MOPSO, TAPSO and TES; and (c) at least one sodium salt of an N-substituted aminosulfonic acid selected from the group consisting of NaBES, NaDIPSO, NaHEPES, NaMOPS, NaMOPSO, NaTAPSO and NaTES where the N-substituted aminosulfonic acid from which the sodium salt is formed is different than the N-substituted aminosulfonic acid selected in (b). - View Dependent Claims (12, 13, 14, 15, 16, 17)
-
-
18. A method to protect the blood pH and the myocardial pH of a patient suffering acute circulatory insufficiency associated with or due to decreased coronary blood flow, said method comprising administering to a patient in need thereof an effective amount of a buffering solution, said buffering solution comprised of:
-
(a) water; (b) at least one N-substituted aminosulfonic acid selected from the group consisting of BES, DIPSO, HEPES, MOPS, MOPSO, TAPSO and TES; and (c) at least one sodium salt of an N-substituted aminosulfonic acid selected from the group consisting of NaBES, NaDIPSO, NaHEPES, NaMOPS, NaMOPSO, NaTAPSO and NaTES where the N-substituted aminosulfonic acid from which the sodium salt is formed is different than the N-substituted aminosulfonic acid selected in (b). - View Dependent Claims (19, 20, 21, 22, 23)
-
-
24. A method for buffering the blood pH and the myocardial pH of a hypothermic patient, said method comprising administering to a patient in need thereof an effective amount of a buffering solution, said buffering solution comprised of:
-
(a) water; (b) at least one N-substituted aminosulfonic acid selected from the group consisting of BES, DIPSO, HEPES, MOPS, MOPSO, TAPSO and TES; and (c) at least one sodium salt of an N-substituted aminosulfonic acid selected from the group consisting of NaBES, NaDIPSO, NaHEPES, NaMOPS, NaMOPSO, NaTAPSO and NaTES where the N-substituted aminosulfonic acid from which the sodium salt is formed is different than the N-substituted aminosulfonic acid selected in (b). - View Dependent Claims (25, 26)
-
-
27. A method for buffering the blood pH and the myocardial pH of a hypothermic patient during cardiac surgery with circulatory occlusion, said method comprising administering to a patient in need thereof an effective amount of a buffering solution by coronary infusion, said buffering solution comprised of:
-
(a) water; (b) at least one N-substituted aminosulfonic acid selected from the group consisting of BES, DIPSO, HEPES, MOPS, MOPSO, TAPSO and TES; and (c) at least one sodium salt of an N-substituted aminosulfonic acid selected from the group consisting of NaBES, NaDIPSO, NaHEPES, NaMOPS, NaMOPSO, NaTAPSO and NaTES where the N-substituted aminosulfonic acid from which the sodium salt is formed is different than the N-substituted aminosulfonic acid selected in (b). - View Dependent Claims (28, 29, 30)
-
-
31. A method for buffering the blood pH and the myocardial pH of a hypothermic patient undergoing cardiopulmonary bypass, said method comprising adding a buffering solution to a primary fluid of a heart-lung machine, said buffering solution comprised of:
-
(a) water; (b) at least one N-substituted aminosulfonic acid selected from the group consisting of BES, DIPSO, HEPES, MOPS, MOPSO, TAPSO and TES; and (c) at least one sodium salt of an N-substituted aminosulfonic acid selected from the group consisting of NaBES, NaDIPSO, NaHEPES, NaMOPS, NaMOPSO, NaTAPSO and NaTES where the N-substituted aminosulfonic acid from which the sodium salt is formed is different than the N-substituted aminosulfonic acid selected in (b). - View Dependent Claims (32)
-
Specification